These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8838047)
1. The role of glutamic acid in the pathogenesis of stroke and the development of neuroprotective drugs. Evans SM; Addae JI West Indian Med J; 1995 Dec; 44(4):119-23. PubMed ID: 8838047 [TBL] [Abstract][Full Text] [Related]
2. Glutamate and the glutamate receptor system: a target for drug action. Bleich S; Römer K; Wiltfang J; Kornhuber J Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S33-40. PubMed ID: 12973748 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective drug development in stroke: blood pressure and its impact. McCulloch J J Hypertens Suppl; 1996 Dec; 14(5):S131-8. PubMed ID: 9120670 [TBL] [Abstract][Full Text] [Related]
4. [Neuroprotection by aspirin in cerebrovascular pathology]. Lorenzo Fernández P An R Acad Nac Med (Madr); 2002; 119(2):311-20; discussion 320-6. PubMed ID: 12518657 [TBL] [Abstract][Full Text] [Related]
5. Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression. Sattler R; Rothstein JD Biol Psychiatry; 2007 Jan; 61(2):137-8. PubMed ID: 17223439 [No Abstract] [Full Text] [Related]
7. Perinatal brain injury: from pathogenesis to neuroprotection. Volpe JJ Ment Retard Dev Disabil Res Rev; 2001; 7(1):56-64. PubMed ID: 11241883 [TBL] [Abstract][Full Text] [Related]
8. Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders. Wang SJ; Yang TT Drug News Perspect; 2005 Nov; 18(9):561-6. PubMed ID: 16421629 [TBL] [Abstract][Full Text] [Related]
9. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Pickering M; Cumiskey D; O'Connor JJ Exp Physiol; 2005 Sep; 90(5):663-70. PubMed ID: 15944202 [TBL] [Abstract][Full Text] [Related]
10. [Future treatment of stroke. Brain damage in stroke can be reduced by drugs]. Siesjö BK Lakartidningen; 1993 Sep; 90(36):2958, 2962-4. PubMed ID: 8366724 [No Abstract] [Full Text] [Related]
11. The role of glutamate in the pathophysiology of Parkinson's disease. Blandini F; Greenamyre JT; Nappi G Funct Neurol; 1996; 11(1):3-15. PubMed ID: 8936453 [No Abstract] [Full Text] [Related]
12. [Glutamate neurotransmission and calcium metabolism in cerebral ischaemia and under normal conditions]. Gusev EI; Skvortsova VI Usp Fiziol Nauk; 2002; 33(4):80-93. PubMed ID: 12449809 [TBL] [Abstract][Full Text] [Related]
18. [Glutamate in traumatic brain injuries]. Wager M; Lapierre F; Buffenoir K Neurochirurgie; 2003 May; 49(2-3 Pt 1):97-106. PubMed ID: 12746725 [TBL] [Abstract][Full Text] [Related]
19. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Bauer M; Alda M; Priller J; Young LT; Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087 [TBL] [Abstract][Full Text] [Related]
20. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid. Khansari PS; Halliwell RF Neurochem Int; 2009 Dec; 55(7):683-8. PubMed ID: 19563851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]